NCT00931034已完成不适用
The Effect of South Beach Diet™ Using South Beach Diet™ Products Compared to the American Diabetic Association Diabetes Meal Plan on Body Weight and Satiety in Overweight Diabetic Women
Mondelēz International, Inc.12 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 12
- 主要终点
- Change in body weight from baseline to week 24
研究概览
简要总结
The purpose of this study is to examine the effectiveness of the South Beach Diet and products compared to the American Diabetic Association Diabetes Meal Plan.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female age 18 to 55 years
- •Females of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result
- •Healthy as determined by laboratory results and medical history
- •Waist circumference > 87 cm
- •Stable weight defined as < 4.5 kg gained or lost in past year
- •Agreement to maintain current level of physical activity throughout the study
- •Diagnosed with Type II diabetes mellitus with fasting blood glucose 100 - 250 mg/dl (5.6 - 13.9 mmol/L)
- •Ability to comprehend and complete the questionnaires and forms
- •Agreement to comply with study procedures, test article consumption, and has access to a microwave oven
- •Voluntary, written, informed consent to participate in the study
排除标准
- •Pregnant, breastfeeding, or planning to become pregnant during the course of the trial
- •Use of prescription or over the counter products known to effect weight including but not limited to the following:
- •megestrol acetate;
- •somatropin;
- •sibutramine;
- •orlistat;
- •paroxetine;
- •dextroamphetamine;
- •methylphenidate;
- •atomoxetine;
- •quetiapine;
- •olanzepine;
- •risperidone, within 4 weeks of randomization and during the trial
- •Unstable medication for diabetes mellitus (Dosage must be stable for 90 days prior to randomization), use of insulin is exclusionary
- •Alcohol use > 2 standard alcoholic drinks per day
- •Significant cardiac history defined as a history of:
- •myocardial infarction (MI);
- •coronary angioplasty or bypass graft(s);
- •valvular disease or repair;
- •unstable angina pectoris;
- •transient ischemic attack (TIA);
- •cerebrovascular accidents (CVA);
- •congestive heart failure; or
- •coronary artery disease (CAD)
- •History of or current diagnosis of any cancer (except for successfully treated basal cell carcinoma) diagnosed less than 5 years prior to screening. Subjects with cancer in full remission for more than 5 years are acceptable.
- •Uncontrolled hypertension defined as untreated systolic blood pressure > 160 mmHg and/or diastolic blood pressure > 100 mmHg
- •Unstable renal and/or liver disease
- •History of alcohol or drug abuse within the past year
- •Unstable psychiatric disorder requiring hospitalization within the past 6 months
- •Immunocompromised individuals such as subjects that have undergone organ transplantation or subjects diagnosed with human immunodeficiency virus (HIV)
- •History of hemoglobinopathies such as sickle cell anemia or thalassemia, sideroblastic anemia
- •Participation in another clinical research trial within 30 days prior to randomization and during the trial
- •Significant abnormal liver function as defined as AST and/or ALT > 2 x ULN, and/or bilirubin > 2 x ULN
- •Serum creatinine > 125 umol/L
- •Anemia of any etiology defined as hemoglobin < 110 g/L
- •Uncontrolled and/or untreated thyroid disorder
- •Unstable medications (Dosage must be stable for 90 days prior to randomization)
- •History of food allergies or sensitivities, including lactose intolerance
- •Vegetarians
- •Cognitively impaired and/or unable to give informed consent
- •Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject
结局指标
主要结局
Change in body weight from baseline to week 24
时间窗: 24 weeks
次要结局
- Assess the satiety response to the individual diets(24 weeks)
- Analyze circumference measurements & body composition; blood glucose, HbA1c, insulin, lipid profile, blood pressure & questionnaire responses on food cravings and quality of life(24 weeks)
研究者
研究点 (12)
Loading locations...
相似试验
已完成
不适用
Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in WomenOverweightNCT00932516Mondelēz International, Inc.248
进行中（未招募）
不适用
Effects of Seaweed Extract on Postprandial Response to White BreadGlycemic ControlDiabetes Mellitus RiskGlucose IntolerancePostprandial HyperglycemiaHealthy SubjectsNCT05460884University College Dublin20
已完成
不适用
Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer SurvivorsBreast CancerNCT01414062Columbia University82
Enrolling By Invitation
不适用
Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-ColonoscopyColorectal PolypInflammationDietary InterventionMicrobiotaMetabolomicsColorectal NeoplasmsNCT06603519University of California, San Diego30
Unknown
不适用
An Intervention Study to Assess the Effect of the Mediterranean Diet on the Plasma Fatty Acid ProfileCoronary Artery DiseaseNCT02578329Centro Cardiologico Monzino150